Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Marshall Lucia

Concepts (684)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
106
2025
972
8.440
Why?
Prostate
34
2025
159
4.970
Why?
Finasteride
23
2020
33
2.170
Why?
Prostate-Specific Antigen
29
2023
162
1.270
Why?
Biopsy, Needle
14
2025
183
1.170
Why?
Neoplasm Grading
15
2025
313
1.110
Why?
Biopsy
28
2022
1075
1.080
Why?
Urinary Bladder Neoplasms
8
2024
259
1.080
Why?
Adenocarcinoma
9
2020
927
0.950
Why?
Prostatic Hyperplasia
7
2015
40
0.940
Why?
Telepathology
1
2025
4
0.930
Why?
Prostatitis
7
2020
17
0.890
Why?
Watchful Waiting
1
2025
90
0.870
Why?
Inflammation
15
2021
2919
0.760
Why?
Enzyme Inhibitors
9
2008
823
0.740
Why?
5-alpha Reductase Inhibitors
10
2020
16
0.680
Why?
Male
135
2026
73396
0.680
Why?
Growth Differentiation Factor 15
4
2014
44
0.640
Why?
Prostatectomy
15
2022
93
0.630
Why?
Immunotoxins
3
2025
51
0.600
Why?
Chemoprevention
4
2009
91
0.600
Why?
Anticarcinogenic Agents
5
2015
63
0.590
Why?
Calcitriol
6
2016
59
0.590
Why?
Receptors, Androgen
4
2021
149
0.580
Why?
Pelvic Pain
5
2020
43
0.560
Why?
Carcinoma
4
2011
225
0.560
Why?
Biomarkers, Tumor
11
2021
1339
0.530
Why?
Meningeal Neoplasms
1
2019
95
0.530
Why?
Humans
152
2026
146342
0.520
Why?
Serine Endopeptidases
2
2019
129
0.520
Why?
Middle Aged
70
2026
36619
0.490
Why?
Proteinuria
3
2026
103
0.490
Why?
Aged
61
2025
26432
0.480
Why?
Glomerulonephritis
1
2015
46
0.450
Why?
Selenium
6
2022
48
0.430
Why?
Cystitis, Interstitial
5
2017
20
0.420
Why?
Antineoplastic Agents
8
2024
2219
0.410
Why?
Trinucleotide Repeats
1
2014
31
0.410
Why?
MAP Kinase Kinase Kinases
3
2021
70
0.410
Why?
Proto-Oncogene Proteins c-ets
1
2014
54
0.410
Why?
Gene Expression Regulation, Neoplastic
9
2021
1432
0.400
Why?
Observer Variation
3
2025
356
0.380
Why?
DNA Helicases
3
2021
138
0.380
Why?
Vitamin E
6
2022
123
0.360
Why?
Urothelium
2
2014
33
0.360
Why?
Cell Line, Tumor
15
2025
3545
0.360
Why?
Neoadjuvant Therapy
4
2024
475
0.360
Why?
Vitamin D
4
2020
402
0.340
Why?
Neoplasm Invasiveness
9
2024
504
0.340
Why?
Imaging, Three-Dimensional
5
2017
582
0.340
Why?
Intercellular Signaling Peptides and Proteins
3
2008
372
0.330
Why?
Dietary Supplements
4
2011
587
0.320
Why?
Neoplastic Cells, Circulating
1
2011
81
0.320
Why?
NF-kappa B
1
2014
674
0.320
Why?
Biomarkers
11
2023
4340
0.310
Why?
Bias
4
2016
197
0.310
Why?
Image-Guided Biopsy
5
2017
41
0.300
Why?
Immunohistochemistry
17
2019
1712
0.300
Why?
Brain Neoplasms
1
2019
1325
0.290
Why?
Chronic Pain
3
2020
304
0.290
Why?
Risk Assessment
12
2020
3712
0.280
Why?
DNA-Binding Proteins
4
2021
1468
0.280
Why?
Case-Control Studies
13
2020
3647
0.280
Why?
Proteins
1
2014
1022
0.280
Why?
Tumor Suppressor Protein p53
3
2008
530
0.270
Why?
Testosterone
4
2023
419
0.260
Why?
Neoplasm Recurrence, Local
3
2023
1160
0.260
Why?
Neoplasm Proteins
4
2016
444
0.260
Why?
Polymorphism, Single Nucleotide
7
2020
2240
0.260
Why?
Cell Division
4
2012
736
0.260
Why?
Digital Rectal Examination
5
2018
10
0.250
Why?
Prostatic Diseases
1
2006
3
0.250
Why?
Neoplasm Staging
11
2021
1488
0.250
Why?
Carcinoma, Transitional Cell
3
2014
70
0.250
Why?
Prognosis
11
2021
4351
0.240
Why?
Incidence
9
2016
2936
0.230
Why?
Podocytes
2
2026
80
0.230
Why?
Aged, 80 and over
19
2021
8391
0.230
Why?
Neoplasms, Experimental
2
2017
163
0.230
Why?
Bone Morphogenetic Proteins
1
2006
143
0.230
Why?
Nephrotic Syndrome
1
2026
44
0.230
Why?
Androgens
5
2021
179
0.230
Why?
Unnecessary Procedures
1
2005
56
0.220
Why?
Prostatic Intraepithelial Neoplasia
3
2013
9
0.220
Why?
Protein Tyrosine Phosphatases
2
2016
166
0.220
Why?
Urology
1
2025
63
0.220
Why?
Risk
8
2020
920
0.210
Why?
CD47 Antigen
1
2025
41
0.210
Why?
Diphtheria Toxin
1
2025
61
0.210
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2025
25
0.210
Why?
Models, Anatomic
2
2004
87
0.210
Why?
Interleukin-10
2
2017
310
0.210
Why?
Atrophy
4
2014
199
0.200
Why?
Genetic Predisposition to Disease
6
2020
2488
0.200
Why?
Urinary Retention
1
2023
23
0.200
Why?
Neoplasm Metastasis
7
2021
693
0.200
Why?
Interleukin-2
3
2024
434
0.190
Why?
Carcinoma in Situ
1
2023
45
0.190
Why?
Azotemia
1
2023
13
0.190
Why?
Sezary Syndrome
1
2023
45
0.190
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2020
449
0.190
Why?
Triple Negative Breast Neoplasms
2
2016
220
0.190
Why?
Hypogonadism
1
2023
89
0.190
Why?
Mycosis Fungoides
1
2023
63
0.190
Why?
Membrane Glycoproteins
1
2026
495
0.190
Why?
Lymphoma, T-Cell, Cutaneous
1
2023
43
0.190
Why?
Sensitivity and Specificity
9
2017
1998
0.190
Why?
Severity of Illness Index
5
2007
2921
0.190
Why?
Phenotype
6
2020
3206
0.190
Why?
Hormone Replacement Therapy
1
2023
107
0.180
Why?
Disease Progression
9
2016
2867
0.180
Why?
Risk Factors
14
2021
10921
0.180
Why?
Signal Transduction
11
2026
5246
0.180
Why?
RNA Interference
2
2021
472
0.170
Why?
Animals
29
2026
38107
0.170
Why?
Antigens, CD
2
2015
560
0.170
Why?
Societies, Medical
1
2025
907
0.170
Why?
Mice
20
2026
18297
0.170
Why?
Antioxidants
5
2015
544
0.170
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
Acute Kidney Injury
3
2023
866
0.160
Why?
Retinoids
1
2021
34
0.160
Why?
Gamma Rays
1
2021
56
0.160
Why?
Clinical Trials as Topic
5
2010
1064
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.160
Why?
Equipment Design
3
2017
520
0.160
Why?
PTEN Phosphohydrolase
2
2019
166
0.150
Why?
Azasteroids
2
2012
5
0.150
Why?
Randomized Controlled Trials as Topic
7
2020
1763
0.150
Why?
Carotenoids
2
2021
47
0.150
Why?
Receptors, Calcitriol
3
2010
54
0.150
Why?
Vitamin A
2
2021
60
0.150
Why?
Placebos
4
2020
192
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Fibrosis
2
2021
568
0.150
Why?
Needles
2
2017
61
0.150
Why?
Endothelial Cells
1
2026
876
0.150
Why?
Organ Size
5
2019
465
0.150
Why?
Parenchymal Tissue
1
2019
4
0.140
Why?
Survival Analysis
5
2011
1378
0.140
Why?
Transcriptional Regulator ERG
1
2019
14
0.140
Why?
Gonadal Steroid Hormones
1
2020
143
0.140
Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
Why?
Focal Adhesions
2
2016
47
0.140
Why?
Follow-Up Studies
11
2015
5439
0.140
Why?
Membrane Proteins
2
2021
1130
0.140
Why?
Transforming Growth Factor beta
2
1998
467
0.140
Why?
Reproducibility of Results
5
2017
3416
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2021
1998
0.130
Why?
Rodentia
1
1998
63
0.130
Why?
Image Interpretation, Computer-Assisted
2
2018
295
0.130
Why?
Symptom Flare Up
1
2017
37
0.130
Why?
Reagent Kits, Diagnostic
1
2018
33
0.130
Why?
Rats
8
2024
5586
0.130
Why?
Diagnostic Self Evaluation
1
2017
24
0.130
Why?
Neovascularization, Pathologic
2
2013
287
0.130
Why?
Odds Ratio
4
2021
1077
0.130
Why?
Treatment Outcome
9
2023
11821
0.130
Why?
Biomedical Research
2
2014
729
0.130
Why?
Cell Cycle
3
2021
595
0.130
Why?
Genetic Loci
1
2018
273
0.130
Why?
Neoplasms, Hormone-Dependent
2
2003
33
0.130
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2020
344
0.130
Why?
Predictive Value of Tests
7
2012
2113
0.130
Why?
Carcinoma, Pancreatic Ductal
1
2021
297
0.130
Why?
Bone Neoplasms
1
2019
272
0.120
Why?
Biopsy, Large-Core Needle
2
2016
15
0.120
Why?
Aspirin
1
2020
405
0.120
Why?
Cell Movement
3
2021
951
0.120
Why?
Connective Tissue Growth Factor
3
2013
29
0.120
Why?
Kidney
7
2005
1498
0.120
Why?
Androgen Antagonists
2
2012
91
0.120
Why?
Seminal Vesicles
1
1995
8
0.120
Why?
Sulfates
1
2016
45
0.120
Why?
Blotting, Western
6
2014
1177
0.120
Why?
Interleukin-8
1
2017
268
0.120
Why?
Skin Neoplasms
1
2023
806
0.110
Why?
Endosonography
1
2017
160
0.110
Why?
Ultrasonography, Interventional
1
2017
163
0.110
Why?
Early Detection of Cancer
4
2019
506
0.110
Why?
Actin Cytoskeleton
1
2016
97
0.110
Why?
DNA Damage
3
2009
439
0.110
Why?
B7-1 Antigen
2
2005
55
0.110
Why?
Glomerulosclerosis, Focal Segmental
2
2005
43
0.110
Why?
Endoribonucleases
1
2016
80
0.110
Why?
Xenograft Model Antitumor Assays
4
2025
930
0.110
Why?
Telomere Shortening
1
2015
20
0.110
Why?
Urinary Tract
1
2015
47
0.110
Why?
Lower Urinary Tract Symptoms
1
2016
62
0.110
Why?
Steroids
1
2016
160
0.110
Why?
CD8 Antigens
1
2015
70
0.110
Why?
Maryland
1
2015
67
0.110
Why?
Tumor Microenvironment
1
2019
747
0.110
Why?
Leukocyte Common Antigens
1
2015
86
0.110
Why?
Fatty Acids, Omega-6
1
2015
47
0.110
Why?
Tamoxifen
1
1995
193
0.110
Why?
Chemical Precipitation
1
2014
39
0.110
Why?
Cell Adhesion
1
2016
447
0.110
Why?
Nitric Oxide Synthase
3
2004
233
0.110
Why?
Antigens, Differentiation, Myelomonocytic
1
2015
66
0.110
Why?
Fibromuscular Dysplasia
1
2014
8
0.110
Why?
CD4 Antigens
1
2015
136
0.110
Why?
Stromal Cells
1
2015
123
0.110
Why?
Ehlers-Danlos Syndrome
1
2014
16
0.110
Why?
United States
11
2023
16136
0.110
Why?
Histone Demethylases
1
2014
39
0.100
Why?
Female
24
2026
79499
0.100
Why?
Reference Standards
1
2014
176
0.100
Why?
Cerebral Arteries
1
2014
56
0.100
Why?
Ubiquitin Thiolesterase
1
2014
70
0.100
Why?
Neurofibromatosis 1
1
2014
59
0.100
Why?
Adaptive Immunity
1
2015
173
0.100
Why?
Microscopy, Fluorescence
3
2011
404
0.100
Why?
Kidney Tubular Necrosis, Acute
2
2005
26
0.100
Why?
Ultrasonography
1
2018
788
0.100
Why?
Computer Simulation
5
2018
1014
0.100
Why?
ras Proteins
1
2014
148
0.100
Why?
Optics and Photonics
1
2014
38
0.100
Why?
Fatty Acids, Omega-3
1
2015
145
0.100
Why?
Mice, SCID
2
2025
360
0.100
Why?
Cystic Duct
1
1993
4
0.100
Why?
Immediate-Early Proteins
2
2005
46
0.100
Why?
Research Design
6
2014
1143
0.100
Why?
Mitogen-Activated Protein Kinases
1
2014
288
0.100
Why?
Cystectomy
2
2024
46
0.100
Why?
Veratrum Alkaloids
1
2013
20
0.100
Why?
Prospective Studies
8
2022
8123
0.100
Why?
Cholelithiasis
1
1993
37
0.100
Why?
Survival Rate
5
2021
2092
0.100
Why?
Spectrometry, Fluorescence
1
2014
165
0.100
Why?
Polyglycolic Acid
1
1993
44
0.100
Why?
Body Mass Index
2
2019
2458
0.100
Why?
Adult
24
2026
41087
0.100
Why?
Somatomedins
1
2013
28
0.090
Why?
Specimen Handling
1
2014
178
0.090
Why?
B7-H1 Antigen
1
2015
245
0.090
Why?
Retrospective Studies
8
2024
17438
0.090
Why?
Insulin-Like Growth Factor Binding Proteins
1
2013
26
0.090
Why?
Random Allocation
1
2013
366
0.090
Why?
Antibodies, Monoclonal, Humanized
2
2023
992
0.090
Why?
Disease Models, Animal
5
2023
4580
0.090
Why?
Muscles
2
2024
330
0.090
Why?
Penile Neoplasms
1
1992
7
0.090
Why?
Pancreatic Neoplasms
1
2021
944
0.090
Why?
Deoxycytidine
2
2024
219
0.090
Why?
Penis
1
1992
33
0.090
Why?
Tumor Suppressor Proteins
1
2014
315
0.090
Why?
Double-Blind Method
6
2020
2070
0.090
Why?
Telomerase
1
2014
252
0.090
Why?
Swine
3
2024
821
0.090
Why?
Health Status Disparities
1
2015
322
0.090
Why?
Sterol Regulatory Element Binding Protein 2
3
2005
6
0.090
Why?
Hedgehog Proteins
1
2013
194
0.090
Why?
Sterol Regulatory Element Binding Protein 1
3
2005
56
0.090
Why?
Cisplatin
2
2024
347
0.080
Why?
Caspase 1
2
2002
145
0.080
Why?
Frozen Sections
1
2011
23
0.080
Why?
Isoenzymes
3
2004
294
0.080
Why?
Logistic Models
3
2021
2126
0.080
Why?
Alkylating Agents
1
2010
23
0.080
Why?
Practice Guidelines as Topic
2
2016
1591
0.080
Why?
Mice, Inbred C57BL
8
2023
6034
0.080
Why?
Gonadotropin-Releasing Hormone
1
2012
215
0.080
Why?
Interleukin-18
2
2002
234
0.080
Why?
beta Carotene
1
2010
20
0.080
Why?
Apoptosis
5
2021
2439
0.080
Why?
Cell Separation
1
2011
300
0.080
Why?
In Situ Hybridization, Fluorescence
1
2011
334
0.080
Why?
Myofibromatosis
2
2001
10
0.080
Why?
Metabolomics
1
2016
738
0.080
Why?
Multivariate Analysis
2
2011
1543
0.080
Why?
Cohort Studies
5
2020
6077
0.080
Why?
Antineoplastic Agents, Hormonal
3
2013
196
0.080
Why?
ROC Curve
3
2008
617
0.080
Why?
ErbB Receptors
1
2013
636
0.070
Why?
Patient Acceptance of Health Care
1
2016
881
0.070
Why?
Mammary Glands, Human
1
2010
71
0.070
Why?
Nuclear Proteins
1
2014
740
0.070
Why?
Immunity, Innate
1
2015
844
0.070
Why?
Mammary Glands, Animal
1
2010
124
0.070
Why?
Bacteria
1
2015
766
0.070
Why?
p300-CBP Transcription Factors
1
2009
25
0.070
Why?
Chronic Disease
4
2017
1827
0.070
Why?
Macrophage Activation
1
2010
182
0.070
Why?
TGF-beta Superfamily Proteins
1
2008
5
0.070
Why?
RNA, Neoplasm
2
2006
76
0.070
Why?
Genetic Markers
1
2009
340
0.070
Why?
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
1
2008
7
0.070
Why?
DNA Primers
2
2006
487
0.070
Why?
Time Factors
7
2016
7109
0.070
Why?
Kidney Diseases
2
2005
428
0.070
Why?
Autopsy
4
2013
96
0.070
Why?
BK Virus
1
2008
18
0.070
Why?
Nephritis
1
2008
22
0.070
Why?
Microbiota
1
2015
725
0.070
Why?
Polyomavirus Infections
1
2008
29
0.070
Why?
Vitamins
2
2022
183
0.070
Why?
Carcinoma, Squamous Cell
1
2013
628
0.070
Why?
Antibodies, Monoclonal
4
2024
1512
0.070
Why?
Head and Neck Neoplasms
1
2013
563
0.070
Why?
Cell Hypoxia
1
2008
249
0.070
Why?
Puerto Rico
2
2019
64
0.060
Why?
Oligonucleotide Array Sequence Analysis
2
2006
752
0.060
Why?
Gene Expression Profiling
3
2019
1792
0.060
Why?
Obesity
2
2015
3131
0.060
Why?
Collagen
1
2010
460
0.060
Why?
Nitriles
2
2021
212
0.060
Why?
Doxorubicin
2
2026
416
0.060
Why?
Mice, Nude
3
2014
668
0.060
Why?
Fibroblast Growth Factors
1
2008
187
0.060
Why?
Lymphatic Metastasis
1
2008
335
0.060
Why?
Drosophila melanogaster
1
2009
237
0.060
Why?
Tumor Burden
1
2008
326
0.060
Why?
Rats, Nude
1
2006
24
0.060
Why?
Postpartum Period
1
2010
377
0.060
Why?
Cell Proliferation
3
2021
2502
0.060
Why?
Lysine
1
2009
303
0.060
Why?
Caspases
2
2010
233
0.060
Why?
Antigens, Neoplasm
2
2007
271
0.060
Why?
Canada
2
2019
432
0.060
Why?
Kidney Neoplasms
1
2010
419
0.060
Why?
Transplantation, Heterologous
1
2006
165
0.060
Why?
Magnetic Resonance Imaging
2
2017
3926
0.060
Why?
Cholestenone 5 alpha-Reductase
1
2005
4
0.060
Why?
Integrin beta1
1
2026
31
0.060
Why?
Scleroderma, Systemic
1
2007
124
0.060
Why?
Calcium
1
2012
1181
0.060
Why?
Kallikreins
2
2018
25
0.060
Why?
Cell Line
4
2014
2814
0.060
Why?
Sterol Regulatory Element Binding Proteins
1
2005
3
0.060
Why?
CCAAT-Enhancer-Binding Proteins
1
2005
36
0.060
Why?
Animal Feed
1
2005
50
0.060
Why?
Polymorphism, Genetic
1
2008
612
0.060
Why?
Drug Screening Assays, Antitumor
2
2016
194
0.060
Why?
Receptors, Complement
1
2026
126
0.060
Why?
Kidney Glomerulus
1
2026
129
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2005
974
0.050
Why?
Tumor Cells, Cultured
2
2021
882
0.050
Why?
Urinalysis
2
2015
82
0.050
Why?
Longitudinal Studies
3
2020
3017
0.050
Why?
Lipid Metabolism
2
2005
533
0.050
Why?
Cell Adhesion Molecules
1
2006
180
0.050
Why?
Transforming Growth Factor beta1
1
2026
176
0.050
Why?
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
2
2014
10
0.050
Why?
Protein Processing, Post-Translational
2
2013
487
0.050
Why?
Vascular Endothelial Growth Factor A
2
2005
545
0.050
Why?
Transcriptional Activation
1
2006
369
0.050
Why?
Carcinoma, Lobular
1
2005
59
0.050
Why?
Carcinoma, Ductal, Breast
1
2005
92
0.050
Why?
Kidney Failure, Chronic
2
2008
589
0.050
Why?
Receptors, CCR4
1
2024
22
0.050
Why?
Doxazosin
1
2003
2
0.050
Why?
DNA Methylation
1
2009
725
0.050
Why?
Reactive Nitrogen Species
1
2004
16
0.050
Why?
Genotype
3
2020
1879
0.050
Why?
Weight Gain
1
2008
562
0.050
Why?
Adrenergic alpha-Antagonists
1
2003
34
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
76
0.050
Why?
DNA Fingerprinting
1
2003
28
0.050
Why?
Complement Pathway, Alternative
1
2005
123
0.050
Why?
Image Processing, Computer-Assisted
2
2005
778
0.050
Why?
Swine, Miniature
1
2024
88
0.050
Why?
Models, Statistical
1
2008
669
0.050
Why?
Biliary Atresia
1
2005
162
0.050
Why?
Germinoma
1
2003
10
0.050
Why?
Body Weight
3
2020
968
0.050
Why?
Endotoxins
1
2004
215
0.050
Why?
Karyotyping
1
2003
106
0.050
Why?
Caloric Restriction
1
2005
133
0.050
Why?
Administration, Intravesical
1
2023
15
0.050
Why?
Acute-Phase Reaction
1
2023
37
0.050
Why?
BCG Vaccine
1
2023
26
0.050
Why?
Keratins
1
2003
57
0.050
Why?
Histones
1
2009
670
0.050
Why?
Liver Cirrhosis
1
2005
278
0.050
Why?
Syndrome
2
2014
380
0.050
Why?
Furosemide
1
2023
37
0.050
Why?
Causality
1
2004
128
0.050
Why?
Clinical Trials, Phase III as Topic
2
2016
116
0.050
Why?
Cyclooxygenase 2
1
2004
166
0.050
Why?
DNA, Neoplasm
1
2003
160
0.050
Why?
Heart Neoplasms
1
2003
56
0.050
Why?
Mice, Inbred NOD
1
2025
598
0.050
Why?
Lipocalin-2
1
2023
80
0.050
Why?
Combined Modality Therapy
3
2010
1271
0.050
Why?
Glomerular Filtration Rate
2
2023
745
0.050
Why?
Interdisciplinary Communication
2
2014
200
0.050
Why?
Mice, Knockout
3
2026
3125
0.050
Why?
Smoking
1
2010
1486
0.050
Why?
Mortality
1
2005
375
0.050
Why?
Peptide Elongation Factors
1
2022
15
0.040
Why?
Testicular Neoplasms
1
2003
108
0.040
Why?
Estradiol
1
2006
517
0.040
Why?
Prevalence
4
2015
2861
0.040
Why?
Drug Resistance, Neoplasm
2
2021
893
0.040
Why?
Adjuvants, Immunologic
1
2023
245
0.040
Why?
Precancerous Conditions
1
2003
162
0.040
Why?
Macrophages
1
2010
1532
0.040
Why?
Promoter Regions, Genetic
1
2006
1242
0.040
Why?
Aging
3
2010
1996
0.040
Why?
Cross-Sectional Studies
3
2020
5899
0.040
Why?
Kidney Transplantation
1
2008
735
0.040
Why?
Microtubule-Associated Proteins
1
2002
187
0.040
Why?
Angiofibroma
1
2001
6
0.040
Why?
Hemangiopericytoma
1
2001
5
0.040
Why?
Phenylthiohydantoin
1
2021
44
0.040
Why?
Histiocytoma, Benign Fibrous
1
2001
7
0.040
Why?
Carcinoma, Non-Small-Cell Lung
1
2010
1195
0.040
Why?
Retreatment
1
2021
79
0.040
Why?
Leukocytes, Mononuclear
1
2024
585
0.040
Why?
Sarcoma
1
2003
209
0.040
Why?
Reactive Oxygen Species
1
2004
610
0.040
Why?
Ephrin-B2
1
2021
45
0.040
Why?
Growth Substances
1
2001
136
0.040
Why?
Cross-Over Studies
2
2017
615
0.040
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
237
0.040
Why?
Diagnosis, Differential
3
2014
1503
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2020
18
0.040
Why?
Dutasteride
2
2012
5
0.040
Why?
Benzamides
1
2021
226
0.040
Why?
Proportional Hazards Models
2
2015
1331
0.040
Why?
Antibodies
2
2002
400
0.040
Why?
Lipids
1
2005
714
0.040
Why?
Trans-Activators
1
2022
372
0.040
Why?
Neutrophils
2
2002
1133
0.040
Why?
alpha-Tocopherol
2
2010
33
0.040
Why?
Perineum
1
2019
36
0.040
Why?
Homeodomain Proteins
1
2003
525
0.040
Why?
Hypertension, Renovascular
1
1999
15
0.040
Why?
Soft Tissue Neoplasms
1
2001
133
0.040
Why?
Ovarian Neoplasms
1
2005
604
0.040
Why?
Creatinine
3
2008
511
0.040
Why?
Metabolic Networks and Pathways
1
2020
175
0.040
Why?
Interleukin-6
1
2023
784
0.040
Why?
Tumor Necrosis Factor-alpha
1
2004
1224
0.040
Why?
Triglycerides
3
2005
527
0.040
Why?
Tissue Array Analysis
1
2018
49
0.040
Why?
Computer-Aided Design
1
2018
39
0.030
Why?
Polycystic Kidney, Autosomal Dominant
1
2002
244
0.030
Why?
Flutamide
1
1998
7
0.030
Why?
Polymerase Chain Reaction
3
2009
1031
0.030
Why?
Tissue Kallikreins
1
2018
2
0.030
Why?
Automation
1
2018
104
0.030
Why?
Dihydrotestosterone
1
1998
40
0.030
Why?
Finite Element Analysis
1
2018
67
0.030
Why?
RNA-Binding Proteins
1
2022
465
0.030
Why?
Diagnosis, Computer-Assisted
1
2018
92
0.030
Why?
Ischemia
1
2001
421
0.030
Why?
Neuroimaging
1
2020
307
0.030
Why?
Phosphorylation
2
2013
1724
0.030
Why?
Life Expectancy
1
1998
72
0.030
Why?
Urological Agents
1
2017
3
0.030
Why?
Confidence Intervals
2
2008
329
0.030
Why?
Radiotherapy, Adjuvant
2
2009
222
0.030
Why?
Kidney Function Tests
2
2008
156
0.030
Why?
Transcription Factors
1
2005
1730
0.030
Why?
Phantoms, Imaging
1
2018
160
0.030
Why?
Age Factors
2
2019
3347
0.030
Why?
Matrix Metalloproteinase 10
1
2016
3
0.030
Why?
Nitric Oxide
2
2004
883
0.030
Why?
Lung Neoplasms
1
2010
2675
0.030
Why?
rac GTP-Binding Proteins
1
2016
35
0.030
Why?
Laminin
1
2016
72
0.030
Why?
Cadaver
1
2017
304
0.030
Why?
Methylnitrosourea
1
1995
7
0.030
Why?
rhoA GTP-Binding Protein
1
2016
76
0.030
Why?
Medical History Taking
1
2016
117
0.030
Why?
Cytokines
1
2004
2081
0.030
Why?
Rectum
1
2017
180
0.030
Why?
Down-Regulation
1
1998
614
0.030
Why?
src-Family Kinases
1
2016
93
0.030
Why?
Tosyl Compounds
1
2015
17
0.030
Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
2
2005
6
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
174
0.030
Why?
Basement Membrane
2
2005
33
0.030
Why?
Oncogenes
1
2016
113
0.030
Why?
Chromatography, Thin Layer
1
2015
24
0.030
Why?
Urine
1
2015
63
0.030
Why?
Chromosomal Instability
1
2015
21
0.030
Why?
Genetic Association Studies
1
2017
379
0.030
Why?
Dose-Response Relationship, Drug
3
2007
2022
0.030
Why?
Carcinogens
1
1995
112
0.030
Why?
Anilides
1
2015
83
0.030
Why?
Prolactinoma
1
2014
13
0.030
Why?
Telomere Homeostasis
1
2015
35
0.030
Why?
Cystotomy
1
2014
3
0.030
Why?
Computational Biology
1
2019
678
0.030
Why?
Arginine
1
1996
264
0.030
Why?
Liver
1
2023
1864
0.030
Why?
Electrophoresis, Polyacrylamide Gel
1
2014
326
0.030
Why?
RNA, Messenger
4
2005
2791
0.030
Why?
BRCA1 Protein
1
2014
84
0.030
Why?
Surveys and Questionnaires
3
2013
6073
0.030
Why?
Chi-Square Distribution
1
2015
517
0.030
Why?
Transfection
1
2016
916
0.030
Why?
Support Vector Machine
1
2014
33
0.030
Why?
Least-Squares Analysis
1
2014
73
0.030
Why?
Phospholipids
1
2015
215
0.020
Why?
Sodium Tetradecyl Sulfate
1
1993
2
0.020
Why?
Cholesterol
2
2005
411
0.020
Why?
Integrin alphaVbeta3
1
2013
20
0.020
Why?
Cadherins
1
2015
202
0.020
Why?
Two-Hybrid System Techniques
1
2013
59
0.020
Why?
Pain Measurement
1
2016
573
0.020
Why?
Focal Adhesion Kinase 1
1
2013
32
0.020
Why?
Sclerotherapy
1
1993
18
0.020
Why?
Extracellular Matrix
2
2010
565
0.020
Why?
Receptor Cross-Talk
1
2013
24
0.020
Why?
Electrocoagulation
1
1993
35
0.020
Why?
Referral and Consultation
1
2019
881
0.020
Why?
In Situ Hybridization
2
2005
317
0.020
Why?
Chromosome Aberrations
2
2003
167
0.020
Why?
Cholecystectomy, Laparoscopic
1
1993
59
0.020
Why?
Cetuximab
1
2013
110
0.020
Why?
Mass Spectrometry
1
2016
729
0.020
Why?
Human Umbilical Vein Endothelial Cells
1
2013
106
0.020
Why?
Kidney Tubules
2
2005
117
0.020
Why?
Up-Regulation
1
2015
841
0.020
Why?
Gene Silencing
1
2013
200
0.020
Why?
Fatty Acids
2
2005
460
0.020
Why?
Urinary Bladder
1
2014
194
0.020
Why?
Alleles
1
2015
907
0.020
Why?
Databases, Factual
1
2018
1493
0.020
Why?
Interferon-gamma
1
2015
781
0.020
Why?
Breast Neoplasms
1
2005
2418
0.020
Why?
Receptors, Steroid
1
1992
41
0.020
Why?
Blood Chemical Analysis
1
2012
109
0.020
Why?
Caspase 3
2
2002
240
0.020
Why?
Flow Cytometry
1
2015
1163
0.020
Why?
Cardiovascular Diseases
1
2023
2219
0.020
Why?
Gene Expression
1
1996
1463
0.020
Why?
Cyclin A
1
2010
17
0.020
Why?
Alkylation
1
2010
27
0.020
Why?
Kaplan-Meier Estimate
1
2013
970
0.020
Why?
Cocarcinogenesis
1
2010
9
0.020
Why?
Cytochromes
1
2010
10
0.020
Why?
Amino Acid Sequence
3
2002
2092
0.020
Why?
Immunoenzyme Techniques
1
2010
197
0.020
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2010
32
0.020
Why?
Young Adult
2
2020
14330
0.020
Why?
Receptors, Retinoic Acid
1
2010
44
0.020
Why?
Cyclin D1
1
2010
64
0.020
Why?
Molecular Sequence Data
3
2002
2838
0.020
Why?
Algorithms
1
1998
1849
0.020
Why?
Alzheimer Disease
1
1996
641
0.020
Why?
Weaning
1
2010
50
0.020
Why?
Ki-67 Antigen
1
2010
120
0.020
Why?
Reference Values
2
2005
796
0.020
Why?
Pilot Projects
1
2015
1888
0.020
Why?
Retinoblastoma-Binding Protein 4
1
2009
3
0.020
Why?
Matrix Metalloproteinases
1
2010
95
0.020
Why?
Selenomethionine
1
2008
3
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2010
178
0.020
Why?
Sirtuin 1
1
2009
35
0.020
Why?
Silymarin
1
2010
147
0.020
Why?
Sirtuin 2
1
2009
27
0.020
Why?
Species Specificity
1
2010
543
0.020
Why?
Sirtuins
1
2009
50
0.020
Why?
Multicenter Studies as Topic
1
2010
417
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2010
441
0.020
Why?
Ethanol
1
1993
630
0.020
Why?
Chromosomal Proteins, Non-Histone
1
2009
131
0.020
Why?
Acetylation
1
2009
262
0.020
Why?
Cell Count
1
2008
315
0.020
Why?
Insulin-Like Growth Factor I
1
2010
320
0.020
Why?
Adolescent
4
2014
22557
0.020
Why?
Transcriptome
1
2014
1068
0.020
Why?
RNA Stability
1
2008
119
0.020
Why?
Histone Deacetylases
1
2009
208
0.020
Why?
Cells, Cultured
1
2015
4118
0.020
Why?
Statistics, Nonparametric
1
2008
426
0.020
Why?
HeLa Cells
1
2009
636
0.020
Why?
Neurons
1
1996
1668
0.020
Why?
Preventive Medicine
1
2007
38
0.020
Why?
Molecular Chaperones
1
2009
200
0.020
Why?
Drosophila Proteins
1
2009
207
0.020
Why?
Protein Binding
1
2013
2244
0.020
Why?
Cell Differentiation
1
2014
1982
0.020
Why?
Incidental Findings
1
2007
81
0.020
Why?
Probability
1
2007
309
0.020
Why?
Enzyme Induction
2
1996
87
0.020
Why?
Radiotherapy Dosage
1
2006
289
0.010
Why?
Periodic Acid-Schiff Reaction
1
2005
2
0.010
Why?
ATP Citrate (pro-S)-Lyase
1
2005
4
0.010
Why?
Biliary Tract
1
2005
13
0.010
Why?
Adenocarcinoma, Clear Cell
1
2005
14
0.010
Why?
Area Under Curve
1
2006
335
0.010
Why?
Linear Models
1
2008
857
0.010
Why?
Densitometry
1
2005
36
0.010
Why?
Collagen Type IV
1
2005
26
0.010
Why?
Azo Compounds
1
2005
30
0.010
Why?
Congresses as Topic
1
2007
226
0.010
Why?
Disease-Free Survival
1
2007
778
0.010
Why?
Neoplasms
2
2013
2954
0.010
Why?
Carcinoma, Endometrioid
1
2005
49
0.010
Why?
Drug Administration Schedule
1
2007
790
0.010
Why?
Graft Survival
1
2008
523
0.010
Why?
Forecasting
1
2007
388
0.010
Why?
Skin Diseases
1
2007
144
0.010
Why?
Plasminogen Activator Inhibitor 1
1
2005
83
0.010
Why?
Preoperative Care
1
2008
396
0.010
Why?
Rats, Inbred F344
1
2005
266
0.010
Why?
Cell Cycle Proteins
1
2009
630
0.010
Why?
Adenocarcinoma, Mucinous
1
2005
76
0.010
Why?
Glycosylation
1
2005
177
0.010
Why?
Fibronectins
1
2005
136
0.010
Why?
Complement C3d
1
2005
67
0.010
Why?
Administration, Oral
1
2007
872
0.010
Why?
Cystadenocarcinoma, Serous
1
2005
90
0.010
Why?
Renal Circulation
1
2004
75
0.010
Why?
Nitric Oxide Synthase Type II
1
2004
162
0.010
Why?
Anxiety
1
2012
1125
0.010
Why?
Breast
1
2005
155
0.010
Why?
Rats, Sprague-Dawley
1
2010
2537
0.010
Why?
Spectral Karyotyping
1
2003
5
0.010
Why?
Brain
1
1996
2991
0.010
Why?
Perfusion
1
2005
255
0.010
Why?
Nitric Oxide Synthase Type III
1
2004
199
0.010
Why?
Oxidative Stress
1
2010
1369
0.010
Why?
Leptin
1
2005
248
0.010
Why?
Sodium
1
2004
196
0.010
Why?
Infant
3
2005
10114
0.010
Why?
Mutation
1
2014
4093
0.010
Why?
Hypoxia
1
2010
1211
0.010
Why?
Vena Cava, Inferior
1
2003
80
0.010
Why?
Amino Acid Chloromethyl Ketones
1
2002
24
0.010
Why?
Renal Dialysis
1
2007
461
0.010
Why?
Heart Atria
1
2003
139
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
48
0.010
Why?
Caspase Inhibitors
1
2002
81
0.010
Why?
Inhibitor of Apoptosis Proteins
1
2002
45
0.010
Why?
Colorado
1
2012
4595
0.010
Why?
Morbidity
1
2003
319
0.010
Why?
Lymphocyte Depletion
1
2002
135
0.010
Why?
bcl-X Protein
1
2002
44
0.010
Why?
In Situ Nick-End Labeling
1
2002
120
0.010
Why?
Cell Nucleus
1
2005
584
0.010
Why?
Antiviral Agents
1
2008
779
0.010
Why?
Kidney Tubules, Proximal
1
2002
127
0.010
Why?
Poly(ADP-ribose) Polymerases
1
2002
88
0.010
Why?
Genomics
1
2007
853
0.010
Why?
Mucous Membrane
1
2002
130
0.010
Why?
Neutralization Tests
1
2001
74
0.010
Why?
Quinolines
1
2002
191
0.010
Why?
Lipopolysaccharides
1
2004
861
0.010
Why?
Analysis of Variance
1
2003
1298
0.010
Why?
Drug Therapy, Combination
1
2003
1036
0.010
Why?
Mice, Mutant Strains
1
2001
290
0.010
Why?
Peroxidase
1
2001
168
0.010
Why?
Mice, Transgenic
1
2006
2134
0.010
Why?
Echocardiography
1
2003
645
0.010
Why?
Proteomics
1
2007
1203
0.010
Why?
Mass Screening
1
2008
1307
0.010
Why?
Inflammation Mediators
1
2002
508
0.010
Why?
Epithelial Cells
1
2005
1119
0.010
Why?
RNA
1
2005
926
0.010
Why?
False Negative Reactions
1
1998
61
0.010
Why?
Diet
1
2006
1273
0.010
Why?
Child, Preschool
2
2005
11913
0.010
Why?
Blood Pressure
1
2004
1765
0.010
Why?
Models, Biological
1
2005
1761
0.010
Why?
Lung
1
2010
4122
0.010
Why?
Pregnancy
1
2010
7230
0.010
Why?
omega-N-Methylarginine
1
1996
29
0.010
Why?
Antibody Specificity
1
1996
181
0.010
Why?
NG-Nitroarginine Methyl Ester
1
1996
48
0.010
Why?
Blotting, Northern
1
1996
197
0.010
Why?
Immunoblotting
1
1996
294
0.010
Why?
Nitrites
1
1996
85
0.010
Why?
Cardiomyopathy, Dilated
1
1999
357
0.010
Why?
Nitrates
1
1996
97
0.010
Why?
Blood Glucose
1
2005
2360
0.010
Why?
Endothelium, Vascular
1
2001
952
0.010
Why?
Child
2
2005
22693
0.010
Why?
Metribolone
1
1992
3
0.010
Why?
Centrifugation, Density Gradient
1
1992
37
0.010
Why?
Peptide Fragments
1
1996
693
0.010
Why?
Chromatography, Affinity
1
1992
82
0.010
Why?
Binding, Competitive
1
1992
185
0.010
Why?
Cytosol
1
1992
215
0.010
Why?
Myocardium
1
1996
948
0.010
Why?
Infant, Newborn
1
2001
6460
0.000
Why?
Kinetics
1
1992
1553
0.000
Why?
Tomography, X-Ray Computed
1
1999
2786
0.000
Why?
Lucia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)